| Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products BD Glass, A Haywood Journal of Pharmacy and Pharmaceutical Sciences 9 (3), 398-426, 2006 | 190 | 2006 |
| Pharmaceutical excipients–where do we begin? A Haywood, BD Glass Australian prescriber 34 (4), 2011 | 161 | 2011 |
| Corticosteroids for the management of cancer‐related pain in adults A Haywood, P Good, S Khan, A Leupp, S Jenkins-Marsh, K Rickett, ... Cochrane Database of Systematic Reviews, 2015 | 101 | 2015 |
| The biological activity of selected cyclic dipeptides PJ Milne, AL Hunt, K Rostoll, JJ Van Der Walt, CJM Graz Journal of Pharmacy and Pharmacology 50 (12), 1331-1337, 1998 | 99 | 1998 |
| Antimicrobial activity of selected cyclic dipeptides M Graz, A Hunt, H Jamie, G Grant, P Milne Pharmazie 54 (10), 772-775, 1999 | 88 | 1999 |
| Liquid dosage forms extemporaneously prepared from commercially available products–considering new evidence on stability A Haywood, BD Glass Journal of Pharmacy and Pharmaceutical Sciences 16 (3), 441-455, 2013 | 79 | 2013 |
| Boosting morale and improving performance in the nursing setting P Stapleton, A Henderson, DK Creedy, M Cooke, E Patterson, ... Journal of Nursing Management 15 (8), 811-816, 2007 | 76 | 2007 |
| Solid medication dosage form modification at the bedside and in the pharmacy of Queensland hospitals LM Nissen, A Haywood, KJ Steadman Journal of pharmacy practice and research 39 (2), 129-134, 2009 | 68 | 2009 |
| Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of … P Good, A Haywood, G Gogna, J Martin, P Yates, R Greer, J Hardy BMC palliative care 18, 1-7, 2019 | 66 | 2019 |
| Enhancement and suppression of ionization in drug analysis using HPLC-MS/MS in support of therapeutic drug monitoring: a review of current knowledge of its minimization and … R George, A Haywood, S Khan, M Radovanovic, J Simmonds, R Norris Therapeutic Drug Monitoring 40 (1), 1-8, 2018 | 60 | 2018 |
| Cyclic dipeptides in the induction of maturation for cancer therapy CJM Graz, GD Grant, SC Brauns, A Hunt, H Jamie, PJ Milne Journal of Pharmacy and Pharmacology 52 (1), 75-82, 2000 | 57 | 2000 |
| Development, validation and application of an HPLC–MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva SR Bista, M Lobb, A Haywood, J Hardy, A Tapuni, R Norris Journal of Chromatography B 960, 27-33, 2014 | 55 | 2014 |
| Therapeutic challenges in cancer pain management: a systematic review of methadone P Good, B Afsharimani, R Movva, A Haywood, S Khan, J Hardy Journal of pain & palliative care pharmacotherapy 28 (3), 197-205, 2014 | 51 | 2014 |
| Micronutrient therapy for violent and aggressive male youth: an open-label trial JL Hambly, K Francis, S Khan, KS Gibbons, WJ Walsh, B Lambert, ... Journal of child and adolescent psychopharmacology 27 (9), 823-832, 2017 | 45 | 2017 |
| Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults A Haywood, J Duc, P Good, S Khan, K Rickett, P Vayne-Bossert, ... Cochrane Database of Systematic Reviews, 2019 | 40 | 2019 |
| Promoting and providing expert guidance in work-intensive clinical settings AJ Henderson, H Alexander, A Haywood, P Stapleton, M Cooke, ... Vocations and Learning 3, 141-156, 2010 | 37 | 2010 |
| Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery) P Vayne‐Bossert, A Haywood, P Good, S Khan, K Rickett, JR Hardy Cochrane Database of Systematic Reviews, 2017 | 36 | 2017 |
| Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein SR Bista, A Haywood, J Hardy, M Lobb, A Tapuni, R Norris Xenobiotica 45 (3), 207-212, 2015 | 33 | 2015 |
| Stability of frusemide tablets repackaged in dose administration aids L Bowen, M Mangan, A Haywood, B Glass Journal of Pharmacy Practice and Research 37 (3), 178-181, 2007 | 30 | 2007 |
| Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of … J Hardy, A Haywood, G Gogna, J Martin, P Yates, R Greer, P Good Trials 21, 1-8, 2020 | 29 | 2020 |
